All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| VIVO / Meridian Bioscience Inc. Call
|
|
|
|
|
|
|
|
| ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| RLYP / Relypsa, Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| SHAK / Shake Shack Inc.
|
|
|
|
|
|
|
|
| LENSF / Presbia PLC
|
|
|
|
|
|
|
|
| 76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SSRG / Symmetry Surgical Inc.
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp. Put
|
|
|
|
|
|
|
|
| US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
| KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
| MDRX / Veradigm Inc.
|
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ZSPH / ZS Pharma, Inc.
|
|
|
|
|
|
|
|
| IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
| GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
| Arrowhead Research Corp
/ (042797209) |
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ANIK / Anika Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
| TTOO / T2 Biosystems, Inc.
|
|
|
|
|
|
|
|
| USO / United States Oil Fund, LP - Limited Partnership Call
|
|
|
|
|
|
|
|
| TARO / Taro Pharmaceutical Industries Ltd.
|
|
|
|
|
|
|
|
| TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
| CYTR / LadRx Corp
|
|
|
|
|
|
|
|
| TLT / iShares Trust - iShares 20+ Year Treasury Bond ETF
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| BRK.B / Berkshire Hathaway Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| TRGT / Targacept
|
|
|
|
|
|
|
|
| FBIO / Fortress Biotech, Inc.
|
|
|
|
|
|
|
|
| DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MNKD / MannKind Corporation Put
|
|
|
|
|
|
|
|
| LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
